MgSO4/CisA: Effect of MgSO4 Pretreatment on Muscle Relaxation
Study Details
Study Description
Brief Summary
In this study, the effect of magnesium sulphate on the onset and duration of intense and moderate cis-atracurium induced neuromuscular blocking and on the period of no response to nerve stimulation will be evaluated in patients who will recieve magnesium sulphate (intervention group) and patients who will not recieve magnesium sulphate (comparator group).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
General anesthesia is a drug-induced reversible state consisting of unconsciousness, amnesia, anti-nociception, and immobility, with maintenance of physiological stability. Balanced general anesthesia, the most common management strategy used in anesthesia care, entails administering a combination of different agents to create the anesthetic state. There is evidence that balanced general anesthesia uses less of each drug than if the drug were administered alone. This approach is believed to increase the likelihood of a drug's desired effects and reduce the likelihood of its side effects. With addition of adjuvants, Alpha-2 adrenoceptor agonists, such as dexmedetomidine, are known to possess amnesic, analgesic, sympatholytic, and antinociceptive properties, and therefore, can reduce the requirement of anesthetics and opioids intraoperatively. Administration of MgSO4 has also shown significant reduction in the perioperative requirement of propofol, opioids, and muscle relaxants. Magnesium sulphate has gained prominence as an adjuvant drug in multimodal anesthesia and pain medicine. It has several clinical indications including attenuation of the adrenergic response to tracheal intubation and improved peri-operative analgesia. Magnesium sulphate also enhances the action of non-depolarizing neuromuscular blocking drugs, resulting in potentiation of neuromuscular blockade (NMB).The site of magnesium potentiation of neuromuscular blocking drugs is the motor end plate, where magnesium reduces the release of prejunctional acetylcholine, thereby decreasing the muscle membrane excitability. However, limited data exist concerning the effect of magnesium sulphate on the duration of deep or intense NMB and on the period of no response to nerve stimulation.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: MgSo4 A magnesium sulphate infusion (60 mg kg-1, total volume 100 ml, infusion rate 10 ml min-1) 10 min. will be administered before induction of anesthesia |
Drug: Magnesium Sulphate
A magnesium sulphate infusion (60 mg kg-1, total volume 100 ml, infusion rate 10 ml min-1) will be administered to patients 10 min. before induction of anesthesia.
Other Names:
|
| Placebo Comparator: Saline Placebo an intravenous 0.9% saline infusion (total volume 100 ml, infusion rate 10 ml min-1) 10 min. will be administered before induction of anesthesia. |
Drug: Saline
The patients will be pretreated with either an intravenous 0.9% saline infusion (total volume 100 ml, infusion rate 10 ml min-1) 10 min. before induction of anesthesia.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- The duration of the period of no response. [Intraoperative.]
The effect of pretreatment with magnesium sulphate on the duration of the period of no response will be measured with the TOF-Watch SX (Organon Ireland Ltd, Dublin, Ireland). The ulnar nerve near the wrist will be stimulated and the activity of the adductor pollicis (thumb) muscle will be recorded.
Secondary Outcome Measures
- The duration of intense neuromuscular block (minutes) [Intraoperative]
The effect of pretreatment with magnesium sulphate on the duration of the intense neuromuscular block in minutes will be measured with the TOF-Watch SX (Organon Ireland Ltd, Dublin, Ireland). The ulnar nerve near the wrist will be stimulated and the activity of the adductor pollicis (thumb) muscle will be recorded.
- The duration of deep neuromuscular block [Intraoperative.]
The effect of pretreatment with magnesium sulphate on the duration of the deep neuromuscular block in minutes will be measured with the TOF-Watch SX (Organon Ireland Ltd, Dublin, Ireland). The ulnar nerve near the wrist will be stimulated and the activity of the adductor pollicis (thumb) muscle will be recorded.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age group 18-60 years old
-
Both genders
-
Patients who will be scheduled to undergo elective otorhinolaryngological surgery.
-
Patients with BMI between 18.5 and 24.9 Kg/m2.
-
Patients with American Society of Anesthesiologist physical status classification of 1 or 2
Exclusion Criteria:
-
Patients who are less than 18 years old or more than 60 years old.
-
Patients on medications that interfered with muscle activity.
-
Allergy to medications used in this study.
-
Pregnancy or suspected pregnancy.
-
Neuro-muscular diseases.
-
Renal or hepatic impairment.
-
Hypermagnesemia (>2.5 mmol) or hypomagnesemia (<1.7 mmol).
-
Patients refusing to study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Assiut university main hospital, ENT operative theatre | Asyut | Asyut Governorate | Egypt | 71515 |
Sponsors and Collaborators
- Assiut University
Investigators
- Principal Investigator: Hala Abdel-Ghaffar, MD, Professor of anesthesia and intensive care, faculty of medicine, Assiut university, Assiut, Egypt.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 04-2023-200100